Please select one:
For healthcare providers
For people living with an IRD
EYES ON WHAT MATTERS IN IRDs
Ramya, living with an IRD
In up to
76%
of people with an inherited retinal disease (IRD), genetic testing may help identify its genetic cause.
Genetic testing results can help you and your eye specialist create a plan to manage future vision loss, make decisions about your family, and determine your eligibility for FDA-approved treatments as well as for clinical trials of new gene therapies. Plus, it’s recommended by the American Academy of Ophthalmology (AAO).
It took 6 years for my family to get our genetic mutation identified. When that news came back, it was like, wow, we finally know. It’s not a mystery. And that was an amazing feeling.”
— Lisa, living with an IRD
Why genetic testing matters
What’s really at stake when we talk about genetic testing for IRDs? Here are 3 reasons why it’s important.
~7% of vision lost
each year*
People with certain types of inherited retinal disease (IRD) lose their vision more quickly than others. X-linked retinitis pigmentosa (XLRP), the most severe form of retinitis pigmentosa (RP), causes people to lose up to about 7% of their vision each year. Knowing which IRD you have can help you and your eye specialist make a plan to preserve your vision.
Learn about IRDs and XLRP
90% think genetic testing is valuable
Data from more than 200 adult patients with IRDs showed that 90% view genetic testing as a positive step forward.† It can help you and your eye specialist understand and manage your own vision loss, help you make decisions about your family, and determine your eligibility for clinical trials for new treatments.
Understand the benefits of testing
40+ ongoing clinical trials for IRDs
Hope is on the horizon in the form of IRD gene therapy. Genetic testing can determine whether you are eligible for one of the more than 40 ongoing clinical trials to find a solution for people living with an IRD, with some potential treatments showing promise in protecting vision.
Learn about gene therapy